Singapore, Singapore

Rajamani Lakshminarayanan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Singapore Health Services Pte Ltd. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajamani Lakshminarayanan. Retrieved from https://idiyas.com/inventor/rajamani-lakshminarayanan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Rajamani Lakshminarayanan in Retinal Treatment

Introduction

Rajamani Lakshminarayanan is a notable inventor based in Singapore, recognized for his contributions to the field of medical treatments. He has developed a significant patent that addresses retinal angiogenic diseases, showcasing his expertise and commitment to advancing healthcare solutions.

Latest Patents

Lakshminarayanan holds a patent for Angio-3, which is designed for the treatment of retinal angiogenic diseases. This innovative disclosure outlines methods for treating such conditions by administering an effective amount of an Angio-3 peptide. His work in this area represents a crucial advancement in ophthalmology.

Career Highlights

He is currently associated with Singapore Health Services Pte Ltd, where he continues to contribute to medical research and innovation. His role in this organization allows him to collaborate with other professionals in the healthcare sector, further enhancing his impact on patient care.

Collaborations

Some of his notable coworkers include Michael Belkin and Veluchamy Amutha Barathi. Their collective efforts in research and development have fostered an environment of innovation and excellence in their respective fields.

Conclusion

Rajamani Lakshminarayanan's work in developing Angio-3 highlights his dedication to improving treatment options for retinal diseases. His contributions are significant in the ongoing quest for medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…